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Summary 
Recombinant interleukin (IL)-15, derived from a simian kidney epithelial call line, is a chemoat- 
tractant for human blood T lymphocytes  judged by its ability to increase the proportion of cells 
in polarized morphology, to stimulate invasion of collagen gels containing IL-15, and to increase 
the proportion of locomotor cells observed by time-lapse videorecording. The ability of lympho- 
cytes to respond was partly, but not completely, inhibited by pretreatment with anti-IL-2 receptor 
B-chain. The activity of Ib15 was completely abolished by preincubation with aIL-15  but unaffected 
by preincubation with aiD2. No response of monocytes, neutrophils, or B lymphocytes to ILl5 
was observed. 
I 
b15 is a newly described cytokine with an action simi- 
lar to that of IL-2 as an activator of T lymphocyte growth 
(1).  It does not  share  sequence  homology with IL-2, but 
modeling suggests that the three-dimensional structure of 
the two cytokines is similar. Activation of growth of T ceils 
by Ib15 is blocked by treating the cells with antibody to the 
/3 chain of the IL-2 receptor (1), suggesting that Ib15 mediates 
its effects through this receptor.  Ib2 is a known chemoat- 
tractant for T lymphocytes (2, 3) and is more potent, as such, 
than IL-8 or macrophage inflammatory  protein (MIP)-lo~ (4). 
We recently reported that the chemoattractant activity of Ib2 
is blocked by preincubating T cells with anti-IL-2 receptor 
/3-chain (aIb2RB), but not with aIL-2Rot, suggesting a role 
for the IL-2R/3 chain in chemotactic activity (4). Since Ib15 
binds to the Ib2 receptor,  it seems plausible  that IL-15, like 
ID2, is a T  cell attractant. Here, we report a study of the 
chemotactic activity of IL-15 for T  lymphocytes, using sev- 
eral assays which measure different aspects of the response. 
The shape-change (polarization) assay was used to measure 
the initial change from spherical  to polarized morphology, 
which accompanies,  and is a prerequisite for, locomotion; 
a collagen gel invasion assay was used to determine the ca- 
pacity of cytokines to attract cells into a matrix (the prin- 
ciple being similar to that of the more familiar filter assay, 
but  using  a  more  physiological  substratum);  time-lapse 
videorecording to study details of locomotor behavior; and 
a checkerboard filter assay to study the effect of IL-15 gra- 
dients on lymphocyte locomotion. 
Materials and Methods 
Materials.  Purified  recombinant IL-15 derived from a simian 
kidney epithelial  cell line was provided  by Immunex Corp., Seattle, 
WA, and was used at concentrations between 1/~g  and 100 pg/ml. 
This material gave a single band at 14-15 kd on SDS-PAGE and 
induced proliferation of PHA-activated human T cells at concen- 
trations between 0.1 and 10 ng/ml (1). Recombinant  human (rh)Ib2 
was a gift from Glaxo, Geneva, Switzerland. This material gave 
a single  band at 15 kD on SDS-PAGE. Its specific  activity  was 1.6 x 
106 U/mg, and it was used at between 200 and 0.2 U/ml (125- 
0.125 ng/ml), rhIL-2  from R&D Systems,  Inc. (Minneapolis,  MN) 
was also used and gave  similar  chemoattractant  activity to the Glaxo 
material, rhIL-8 was from PeproTech (Rocky Hill, NJ). rhMIP-lo~ 
was  provided by Dr.  G. J.  Graham  (CRC Beatson Institute, 
Glasgow, United Kingdom) and originated from R&D. Mono- 
clonal aID2R~ (MII~I, mouse IgG2a) was provided by Dr. T. 
Tanaka (Tokyo  Metropolitan Institute of Science,  Japan). aID2Ro~ 
was from Dako Corp. (Glostrup, Denmark). Anti-human IL-15 
(mouse  IgG1) was provided  by Immunex Corp. (Seattle,  WA). ahlL-2 
was from  R&D Systems, Inc. FITC-aCD3/PE-aCD19,  FITC- 
aCD4, and FITC-aCD8 were from Dako Corp. Hanks' solution 
(Gibco Ltd., Paisley,  United Kingdom) was buffered  to pH 7.4 with 
Hepes (Sigma, Poole, United Kingdom) and, when necessary, sup- 
plemented with HSA (human serum albumin) 10 mg/ml (HBSS- 
HSA) or 25% FCS (Gibco Ltd.) (HBSS-FCS). 
Cell Preparation.  PBMC were separated from blood on lym- 
phocyte separating medium. The ceils were washed thrice and ei- 
ther resuspended in HBSS-HSA and used immediately for polari- 
zation assays, or cultured for 24 h in HBSS-FCS +  bicarbonate 
in 5% CO2. Monocytes were not removed from the cell prepara- 
tions before testing, because our early experience demonstrated a 
requirement for the presence of  accessory  cells for the development 
of locomotor activity in cultured T cells (5, 6). Locomotor mono- 
cytes were readily distinguished from lymphocytes  by using phase- 
contrast optics or by staining for nonspecific esterase. 
Polarization  Assay.  This assay  measures the change from a spher- 
ical shape to the shape, characterized by head-tail polarity, typical 
of locomotor cells (7, 8). Lymphocytes were suspended at 37~ 
for 30 rain in the presence or absence of chemoattractants, then 
fixed with 2.5% glutaraldehyde.  After washing, the percentage of 
polarized cells was scored by phase-contrast  microscopy  as described 
previously  (8). A negative  control value  was established  using HBSS- 
HSA alone. Lymphocyte polarization was also measured on cells 
that had been cultured for 24 h in HBSS-FCS. After culture, the 
cells were removed from culture medium, washed, and tested in 
30-rain shape-change assays as described above. 
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rat tail tendons (9, 10) and stored in water at pH 4.0. A gel was 
formed by restoring the collagen to physiological pH and osmolarity. 
Gels were cast in 24-well dishes and allowed to set. Cytokines were 
mixed with the collagen immediately before setting. Once the gel 
had set, it was overlaid with lymphocytes, which were allowed to 
settle on the top surface. The gels were incubated at 37~  for 16 h 
to allow the overlaid cells to invade. They were then fixed for 30 
min with glutaraldehyde and washed twice very gently, taking care 
not to decant cells lying on top of the gel, and the proportion of 
cells which had remained on the upper surface and of those which 
had invaded the gel was determined. Duplicate gels were set up 
for each experiment, and cell counts were done in four fields per 
gel. Two measures of locomotor activity were used. The percentage 
of cells which had invaded the gel was determined by counting 
cells at 40-/~m intervals  of depth within the gel.  The distance 
migrated by the leading front of cells was  also determined. 
Time-lapse Videorecording.  Collagen gels containing HBSS were 
prepared as above and cast into metal filming chambers described 
elsewhere (10). Suspensions of PBMC direct from blood were over- 
laid on the upper surface of the gel in HBSS with or without IL-15 
(1/tg/ml). Unactivated lymphocytes attach poorly to protein-coated 
plastic surfaces, which are unsuitable for analysis of their locomo- 
tion. Analysis of locomotion on the surfaces of collagen gels was 
preferred. Since the cytokine was present in the lymphocyte sus- 
pension, but not in the gel, few cells entered the gel and locomo- 
tion on its upper surface could be analyzed,  using a videocamera 
and videorecorder as previously described  (10). The paths of cells 
were traced from the videotapes thus obtained, and the proportion 
of locomotor cells and their speeds and turning behavior were 
measured. 
Checkerboard Filter Assay.  The influence of the absolute con- 
centration and of the gradients of IL-15 was studied using a check- 
erboard filter assay (11, 12). Lymphocytes prepared directly from 
blood were allowed to migrate for 2 h into cellulose ester filters 
(8/~m poresize;  Sartorius,  G6ttingen, Germany) with a checker- 
board of IIA5 concentrations above and below the filter. After fixa- 
tion and staining,  the distance  migrated by the leading front of 
the cells was measured. The distance expected of cells responding 
to absolute concentration alone was calculated  as outlined in the 
appendix to the paper of  Zigmond and Hirsch (11). Distances greater 
than expected in positive gradients and smaller  than expected in 
negative gradients suggest a chemotactic response. 
Treatment of Cells and Cytokines with Specific Antibodies.  Cells 
were incubated with alL-21~ (MII~I) for 2 h at room tempera- 
ture. The antibody was used at 20/tg/ml, as previously determined 
(4, 13). As a control, normal mouse IgG2a was used at the same 
concentration. The cells were then washed to remove free anti- 
bodies and tested against IL-2 and Ib15 in polarization assays. IL-15 
(1/~g/ml-100 ng/ml) or IL-2 (200-20 U/m1) was incubated with 
the anticytokine antibodies aIL-15 (1/250-1/1,000) and alL-2 (1/~g/ 
ml-40 ng/ml) for 1 h at room temperature. Then, the antibody- 
treated and untreated cytokines were tested, using lymphocytes in 
polarization assays. 
Phenotyping of Locoraotor Cells.  To score the proportion of T 
and B cells or of CD4+  and CD8+  cells responding in polariza- 
tion assays, the assay was performed as above, but the cells were 
fixed in paraformaldehyde  (1%), which does not cause autofluores- 
cence of cells and allows them to retain locomotor morphology. 
Cells were washed and stained with appropriate fluorescent anti- 
bodies. Slide and coverslip preparations  were made, and the propor- 
tion of labeled cells in the polarized and the spherical lymphocyte 
populations was determined. 
Results and Discussion 
Response of Lymphocytes to 11,15 and Other Cytokines.  Fig. 
1 shows the polarization dose-response of lymphocytes from 
PBMC preparations, both directly after preparation from blood 
and after 24 h  culture in HBSS-FCS. A  proportion of cells 
from both preparations polarized in response to both II:15 
and Ib2 and the dose responses to the two cytokines were 
similar (EDs0 for Ib2,  5  ng/ml;  for Ib15,  7 ng/ml).  Cul- 
tured cells responded in higher numbers than freshly prepared 
cells, largely due to an increase in background polarization. 
However, they also responded to lower concentrations of both 
cytokines (EDs0 for cultured cells  to Ib2,  0.75  ng/ml;  to 
IL-15, 0.6 ng/ml).  Both IL15 and II.-2 caused more cells to 
polarize (20-35% higher than control) than the chemokines 
Ib8  and MIP-lol,  (10-15%  higher than control)  (Fig.  2), 
though  the EDs0s were similar for all four cytokines.  Pre- 
vious work (2-4) has shown that the cells that respond to 
II.-2 are T  cells, but, since we were using mixed cell popula- 
tions, it was necessary to phenotype the responsive cells to 
determine which population responded to Ib15. When scoring 
polarization in paraformaldehyde-fixed, CD3/CD19-stained 
cells, almost the entire increase in polarized lymphocyte mor- 
phologies can be attributed to T cells (Table 1). Both CD4 + 
and CD8 +  ceils responded, but there was no selectivity of 
either subset.  The CD19+  population showed no increase 
above control levels (not shown).  Cell types other than T 
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Figure 1.  Dose-response  of human blood lymphocytes  to Ib15 (triangles) 
and I1,2 (circles)  in polarization assays. Cells were tested directly after sepa- 
ration (open  symbols)  or after overnight  culture in HBSS-FCS (fiUedsymbols). 
P < 0.01 for both Ib15 and II.2 at concentrations >10 ng/ml, compared 
with the medium control (mean _+ SEM, n  =  6). 
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Figure 2.  Comparison of dose-response of blood lymphocytes to 11215 
with that to I-L-2,  IL-8, and MIP-lot in polarization assays. The figure shows 
responses of cells tested directly after separation from blood. Similar results 
were obtained after overnight  culture (mean  +_  SEM, n  ~  4). 
was seen by using blood monocytes either from whole PBMC 
preparations or after purification on fibronectin-coated sur- 
faces (14, 15). No response was seen by using neutrophils. 
Human tonsiUar B cells were purified by removing T  cells 
by 2-aminoethyl isothiouronium bromide (AET)-rosetting 
(Sigma), followed by separation on Percoli gradients (16). These 
B cells (>97% pure) showed no significant response to 1I.-15 
(M.  Komai-Koma, unpublished observation). 
Time-lapse filming confirmed that cells responding by shape- 
change to II.-15 were also active locomotor cells: 45% oflym- 
phocytes in a uniform concentration of II.-15 (1/~g/ml), but 
Table 1.  T  Cell Polarization in Response to IL-15 
Marker population 
Percent of marker 
positive cells that are 
in 
Percent of  polarized 
all cells  morphology 
that are 
positive for  Medium  IL-15 
marker  control  (1 #g/ml) 
Cells direct from blood 
CD3 




76.4  ~5  44.6 
87.4  24.5  53.5 
59  20.7  47.2 
28.5  24.3  48 
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only 15.1%  of cells in the medium control, showed active 
locomotion on collagen gels. The median speed of the cells 
in 1I.-15 was 5.9/~m/min, and the cells moved by a persistent 
random walk (median displacement; 5.5/~m/min). 
Effect of Anti-ILl5 and Anti.IL2.  The effect of these anti- 
bodies is shown in Table 2. Each antibody strongly inhibited 
lymphocyte shape change induced by its own specific cytokine 
but had little inhibitory effect on the activity of the others. 
Effect of  Anti.IL2Rfl.  Fig. 3 shows that incubation oflym- 
phocytes fresh from blood with alL,2RB (MIKB1) significantly 
reduced their capacity to respond to both II:2 and IL,15. Similar 
results were obtained using lymphocytes cultured overnight 
before incubation with alL-2RB.  Anti-Ib2Ro~ had no in- 
hibitory effect on the response to either cytokine (data not 
shown). 
Collagen Gel Invasion.  The invasion by blood lymphocytes 
of collagen gels containing Ib2 and Ib15 is shown in Table 
3. Overnight, more cells invaded gels containing the cytokines 
than the control gels (these proportions were very similar 
to those for overnight polarization shown in Fig.  1). Also, 
the leading front of cells migrated further in the presence 
than in the absence of cytokines.  Anti-IIr  antibody did 
not completely inhibit the invasion of IL-15-containing gels 
(not shown). Interpretation was difficult, because this anti- 
body (mouse IgG1), itself, attracted lymphocytes into gels, 
and, in unpublished experiments in this laboratory (M. Komai- 
Koma), it was observed that mouse IgG1 may stimulate the 
locomotion of B cells. 
Checkerboard Filter Assay.  Table 4  shows the distances 
migrated by lymphocytes  in a checkerboard assay. Cell migra- 
tion increased as the absolute I1.-15 concentration was increased 
(along the diagonal from upper left to lower right). In posi- 
tive gradients (above the diagonal), migration was greater 
than calculated on the basis of a response to absolute concen- 
tration alone; in negative gradients (below the diagonal), it 
was lower. These results  suggest that Ib15 induces both a 
chemokinetic and a chemotactic response. 
The results presented here show that IL-15 stimulates loco- 
motion of human T  lymphocytes, judged by polarization, 
time-lapse filming, and invasion of collagen gels. A falter check- 
erboard assay suggested that locomotion was enhanced, both 
by increasing the absolute concentration of Ib15 and by ex- 
posing the cells to positive gradients, implying that IIA5 causes 
Table 2.  Inhibitory Effect of alL-15  and alL-2  on Lymphocyte 
Polarization Induced by IL.15 and IL-2 
Percent inhibition of response to 
IL-15  IL-2  IL-2 
Antibody  (100 ng/ml)  (200  U/ml)  (20 U/ml) 
alL-15:1/500  93.8"  0  5 
1/1,000  74.3* 
alL-2:200 ng/ml  16.1  82.7*  85* 
* P <0.01  compare non-antibody-treated control. 
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Figure 3.  Effect  ofpretreatment  of  uncultured  blood  lymphocytes  with 
aIL-2Rq8 on their response to IL-15 and II.,2. The figure shows  results of 
a single experiment. Cells pretreated with medium alone,  filled symbols; 
cells pretreated with alb2R~, open symbols. IL-15, triangles; IL-2, circles. 
P < 0.01 in five  experiments comparing  antibody-treated  with untreated 
cells for both cytokines  at concentrations  >10 ng/ml. 
T cells both to accelerate (chemokinesis) and to move direc- 
tionally (chemotaxis). These results are closely similar to those 
observed with the sister cytokine Ib2, and, wright-for-weight, 
these cytokines are more powerful attractants than I1-8 or 
MIP-la (Fig. 2). There is little homology between the two 
cytokines and there was no cross-inhibition by their respec- 
tive antibodies. As in the first report of T cell activation by 
I1-15 (1), the T cell locomotor activity of this cytokine was 
reduced by pretreatment of the cells with aI1-2RB, though 
inhibition was only partial, suggesting that other cell sur- 
face molecules may contribute to activation by I1-15. Table 
1 shows that 40-50% of the T cell population polarized in 
response to I1-15. Our unpublished observations suggest that 
this was also the groportion which was positive for I1-2R,8, 
judged by FACS  analysis. Moreover,  variations in I1-2RB 
Table  3.  Invasion by Lymphocytes of Collagen Gels Containing 
Cytokines 
Attractant  in gel 
Percent cells  Leading front 
invading gel  value gm/16 h 
(mean  •  SEM)  (mean  +  SEM) 
Medium alone  24.4  •  5.0  154.9  +  21.4 
IL-2 (50 U/ml)  44.6  •  2.4"  261.3  _+  16.1" 
IL-15 (1 /~g/ml)  44.8  +  3.7*  242.8  •  22.7* 
IL-15 (50 ng/ml)  49.4  +  3.0"  223.1  •  16.2~ 
* P <0.01 compare medium control (n  =  8). 
P <0.05 > 0.01 compare medium control (n  =  8). 
expression  in different blood samples were reflected in the 
response  of lymphocytes from those samples to I1-15. 
The role in the migrations ofT lymphocytes  in vivo played 
by the various cytokines that have been reported to attract 
T  lymphocytes in vitro is unknown. The effective concen- 
tration of I1-2,  a cytokine released chiefly by T  cells, as a 
stimulant of T cell locomotion is higher than that required 
to stimulate T cell proliferation, as observed here. The con- 
centrations ofi1-2 found in inflammatory sites, such as rheu- 
matoid synovial fluids and tissues (17), or following stimula- 
tion of  PBMC from normal subjects with PHA (18) or aCD3 
(unpublished observations of the authors) would, based on 
the dose-response  curves shown here, be suboptimal for at- 
tracting T lymphocytes. Moreover, I1-2-gene knockout mice 
are still capable of mounting immune responses that classi- 
cally require I1-2 (19). Possibly, I1-15, which is made by non- 
lymphocytic cells, including mononuclear phagocytes, can 
substitute for IL-2 as a T cell activator under conditions where 
little I1-2 is present, though I1-15 levels in various sites of 
antigen deposition or response to tissue injury are, as yet, 
unknown. 
Other than recruitment into inflammatory  sites, T cell loco- 
motion is probably also important in T  ceU-accessory cell 
Table  4.  Checkerboard Filter Assay 
Distance migrated (gin in 2 h) by leading front of cells (mean  •  SEM) 
IL-15 (ng/ml) below filter 
IL-15 (ng/ml) above filter 
0  10  100  1,000 
0  25  +  3  51  +  3 (27)*  65  +  5 (34)  68  +  4 (49) 
10  45  +  5 (34)  35  -+  5  52  •  6 (37)  44  _+  4 (48) 
100  43  _+  4 (46)  32  +  5 (45)  49  •  3  59  _+  5 (50) 
1,000  46  _+  4 (53)  46  •  4 (53)  49  _+  5 (53)  54  _+  5 
* Figures in parentheses show the calculated  distance that would be migrated ff cells responded to the absolute concentration  of IL-15, but not to 
the gradient (reference 11). They are for comparison with the experimentally  observed distances migrated in each chamber. 
1258  ID15 and T Cell Locomotion interactions. In time-lapse studies of immune cell clustering, 
we observed that clustering occurred chiefly after random con- 
tacts between lymphocytes and accessory cells, but, at very 
close range (within a cell diameter), lymphocytes  showed orien- 
tation towards nearby monocytes, suggesting that the latter 
cells might be releasing an attractant detectable only at close 
range (20).  A  subsequent study showed that monocytes in 
clusters with lymphocytes released large quantities of IL-8, 
suf~cient to stimulate lymphocyte locomotion under condi- 
tions where II.-2 levels were too low to exert an effect (6). 
It will be important to determine whether accessory cells make 
11-15 in sites of  immune reactions and whether this contributes 
to the recruitment of T  cells into such sites. 
We are grateful to Dr. D. Cosman of Immunex Corporation, Seattle, WA, for the generous gifts of 11.,15 
and anti-I1:15. 
This work was supported by grants from the Arthritis and Rheumatism Council and the Wellcome  Trust. 
Address correspondence to Dr. Peter C. Wilkinson, Department of Immunology, University of Glasgow, 
Western Infirmary, Glasgow Gll 6NT, United Kingdom. 
Received for publication 18 October 1994. 
References 
1.  Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. 
Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoen- 
born, M. Ahdieh, et al. 1994. Cloning of a T cell  growth factor 
that interacts with the B-chain of the interleukin-2 receptor. 
Science (Wash. DC). 264:965-968. 
2.  Komfeld, H., J.S. Berman, D.J. Beer, and D.M. Center. 1985. 
Induction of human T lymphocyte motility by interleukin 2. 
J. Immunol. 134:3887-3890. 
3.  potter, J., and D. Van Epps. 1987. Separation and purification 
of  lymphocyte chemotactic factor (LCF) and interhukin 2 pro- 
duced by human peripheral blood mononudear cells. Cell. Im- 
munol. 105:9-22. 
4.  Wilkinson, PC., and I. Newman. 1994. Chemoattractant ac- 
tivity of I1.-2 for human lymphocytes: a requirement for the 
1I:2 receptor ~ chain. Immunology. 82:134-139. 
5.  Wilkinson, PC., and A. Higgins. 1987. OKT3-activated  loco- 
motion of human blood lymphocytes:  a phenomenon requiring 
contact of T cells with Fc receptor-bearing cells. Immunology. 
60:445-451. 
6.  Wilkinson, PC., and I. Newman. 1992. Identification of I1:8 
as a locomotor attractant for activated human lymphocytes in 
mononuclear cell cultures with anti-CD3 or purified protein 
derivative of Mycobacterium tuberculosis..[. Immunol. 149:2689- 
2694. 
7.  Haston, W.S., and J.M. Shields. 1985. Neutrophil leucocyte 
chemotaxis: a simplified  assay  for measuring  polarising  responses 
to chemotactic factors. J. Immunol. Methods. 81:229-237. 
8.  Wilkinson, P.C. 1986. The locomotor capacity  of human lym- 
phocytes and its enhancement by cell growth.  Immunology. 
57:281-289. 
9.  Elsdale, T., and J. Bard. 1972. Collagen substrata for studies 
on cell behavior. J. Cell Biol. 54:626-637. 
10.  Haston, W.S., and P.C. Wilkinson. 1988. Visual methods for 
measuring leukocyte  locomotion. Methods Enzymol. 162:17-38. 
11.  Zigmond, S.H., andJ.G. Hirsch. 1973. Leukocyte  locomotion 
and chemotaxis. New methods for evaluation, and demonstra- 
tion of a cell-derived chemotactic factor. J. Extx Med. 137: 
387-410. 
12.  Wilkinson, PC. 1988. Micropore filter methods for leukocyte 
chemotaxis. Methods Enzymol. 162:38-50. 
13.  Tsudo, M., F. Kitamura, and M. Miyasaka. 1989. Character- 
ization of the interleukin 2 receptor 3 chain using three dis- 
tinct monoclonal antibodies. Proc. Natl. A_cad. Sci. USA. 86: 
1982-1986. 
14.  Ackerman,  S.K., and S.D. Douglas. 1978. Purification  of  human 
monocytes on microexudate-coated  surfaces.J. Immunol. 120: 
1372-1374. 
15.  Islam, L.N., and PC. Wilkinson. 1988. Chemotactic factor- 
induced polarization, receptor redistribution, and locomotion 
of human blood monocytes. Immunology. 64:501-507. 
16.  Gordon, J., G. Guy, and L. Walker. 1985. Autocrine models 
of B-lymphocyte growth. I. Role of cell contact and soluble 
factors in T-independent B-cell responses. Immunology. 56: 
329-335, 
17.  Combe, B., R.M. Pope, M. Fischbach, B. Darnell, S. Baron, 
and N.  Talal. 1985. Interleukin-2 in rheumatoid  arthritis: 
production of and response to interleukin-2 in rheumatoid sy- 
novial fluid, synovial tissue and blood. Clin. Exp. Immunol. 
59:520-528. 
18.  Plater-Zybeck,  C., K.A. Rockett, and R.N. Maini. 1988. Spon- 
taneous recovery of the decreased expression in vitro of inter- 
leukin 2 receptors in rheumatoid arthritis. Clin. Ext~ Immunol. 
73:93-97. 
19.  Kiindig, T.M., H. Schorle, M.F. Bachmann, H. Hengartner, 
R.M. Zinkemagel, and I. Horak. 1993. Immune responses in 
interleukin-2 deficient  mice. Science (Wash. DC). 262:1059-1061. 
20.  Wilkinson, PC. 1990. Relation between locomotion, chemo- 
taxis and clustering of immune cells. Immunology. 69:127-133. 
1259  Wilkinson  and Liew  Brief  Definitive Report 